journal article·2016-10

Gold nanoparticle-DNA aptamer conjugate-assisted delivery of antimicrobial peptide effectively eliminates intracellular Salmonella enterica serovar Typhimurium

Ji-Hyun Yeom, Boeun Lee, Daeyoung Kim, Jong-kook Lee, Suk Kim, Jeehyeon Bae, Yoonkyung Park, Kangseok Lee

Biomaterials· Volume 104
Publisher page

Abstract

Antimicrobial peptides (AMPs) are a promising new class of antibacterial compounds. However, their applications in the treatment of intracellular pathogenic bacteria have been limited by their in vivo instability and low penetrating ability into mammalian cells. Here, we report that gold nanoparticles conjugated with DNA aptamer (AuNP-Apt) efficiently delivered AMPs into mammalian living systems with enhanced stability of the AMPs. C-terminally hexahistidine-tagged A3-APO (A3-APO(His)) AMPs were loaded onto AuNPs conjugated with His-tag DNA aptamer (AuNP-Apt(His)) by simple mixing and were delivered into Salmonella enterica serovar Typhimurium (S. Typhimurium)-infected HeLa cells, resulting in the increased viability of host cells due to the elimination of intracellular S. Typhimurium cells. Furthermore, the intravenous injection of AuNP-Apt(His) loaded with A3-APO(His) into S. Typhimurium-infected mice resulted in a complete inhibition of S. Typhimurium colonization in the mice organs, leading to 100% survival of the mice. Therefore, AuNP-Apt(His) can serve as an innovative platform for AMP therapeutics to treat intracellular bacterial infections in mammals.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Advanced biosensing and bioanalysis techniques · Bacteriophages and microbial interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. Antibiotic entry into human polymorphonuclear leukocytes10.1128/AAC.21.3.373 ↗
2. Antibiotic penetration of and bactericidal activity within endothelial cells10.1128/AAC.38.5.1059 ↗
3. Delivery of antibiotics with polymeric particles10.1016/j.addr.2014.02.002 ↗
4. Novel antibody-antibiotic conjugate eliminates intracellular S. aureus10.1038/nature16057 ↗
5. Immunity to salmonellosis10.1111/j.1600-065X.2010.00999.x ↗
6. Effective control of Salmonella infections by employing combinations of recombinant antimicrobial human beta-defensins hBD-1 and hBD-210.1128/AAC.03628-14 ↗
7. Type III secretion machines: bacterial devices for protein delivery into host cells10.1126/science.284.5418.1322 ↗
8. Microbial pathogenesis and cytoskeletal function10.1038/nature01603 ↗
9. Salmonella enterica serovar Typhimurium regulates intercellular junction proteins and facilitates transepithelial neutrophil and bacterial passage. (vol 293, pg G178, 2007)
10. Determination of antimicrobial resistance in Salmonella spp10.1007/978-1-4939-1625-2_3 ↗
11. The role of cationic antimicrobial peptides in innate host defences10.1016/S0966-842X(00)01823-0 ↗
12. Peptidomimetics as a new generation of antimicrobial agents: current progress10.2147/IDR.S49229 ↗
13. Antimicrobial peptides: versatile biological properties10.1155/2013/675391 ↗
14. Describing the mechanism of antimicrobial peptide action with the interfacial activity model10.1021/cb1001558 ↗
15. Mechanisms of antimicrobial peptide action and resistance10.1124/pr.55.1.2 ↗
16. The development of antimicrobial peptides as new antibacterial drugs10.2174/138920371408131227155308 ↗
17. Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs10.1073/pnas.75.6.2959 ↗
18. In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide10.1002/jps.1115 ↗
19. Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis10.3389/fmicb.2015.00372 ↗
20. Nanoparticle-mediated delivery of the antimicrobial peptide plectasin against Staphylococcus aureus in infected epithelial cells10.1016/j.ejpb.2015.02.009 ↗
21. Antimicrobial peptides targeting gram-negative pathogens, produced and delivered by lactic acid bacteria10.1021/sb4000367 ↗
22. Gold nanoparticle-DNA aptamer composites as a universal carrier for in vivo delivery of biologically functional proteins10.1016/j.jconrel.2014.10.021 ↗
23. Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo10.1110/ps.034330.108 ↗
24. The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models10.1016/j.ijantimicag.2009.10.015 ↗
25. Designer antibacterial peptides kill fluoroquinolone-resistant clinical isolates10.1021/jm050347i ↗
26. A helix-PXXP-helix peptide with antibacterial activity without cytotoxicity against MDRPA-infected mice10.1016/j.biomaterials.2013.10.035 ↗
27. Inhibition of xenograft tumor growth by gold nanoparticle-DNA oligonucleotide conjugates-assisted delivery of BAX mRNA10.1371/journal.pone.0075369 ↗
28. In vitro antibacterial effect of carbamide peroxide on oral biofilm
29. Assessment of bacterial resistance to organic solvents using a combined confocal laser scanning and atomic force microscopy (CLSM/AFM)10.1016/j.mimet.2014.08.020 ↗
30. Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics10.1016/j.peptides.2008.07.016 ↗
31. Revealing the lytic mechanism of the antimicrobial peptide gomesin by observing giant unilamellar vesicles10.1021/la100662a ↗
32. Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions10.1016/j.bbamem.2007.09.020 ↗
33. The antibacterial effect of a proline-rich antibacterial peptide A3-APO10.2174/092986709789352295 ↗
34. Intracellular toxicity of proline-rich antimicrobial peptides shuttled into mammalian cells by the cell-penetrating peptide penetratin10.1128/AAC.00585-12 ↗
35. Animal models of Salmonella infections: enteritis versus typhoid fever10.1016/S1286-4579(01)01495-2 ↗
36. Microbiology. Noninherited resistance to antibiotics10.1126/science.1103077 ↗
37. Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals10.1073/pnas.1203735109 ↗
38. Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity10.1139/o01-236 ↗
39. Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action10.1111/jam.12262 ↗
40. Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action10.1016/j.bbamem.2006.04.006 ↗
41. A mouse model of Salmonella typhi infection10.1016/j.cell.2012.08.042 ↗